Real-world effectiveness and safety of carotegrast methyl in patients with ulcerative colitis: a multicenter retrospective cohort study
Carotegrast methyl demonstrated good efficacy and safety, potentially benefiting patients with low baseline disease activity. This drug may be a useful treatment option to consider before systemic corticosteroid therapy for ulcerative colitis.
Authors
- Makoto Sanomura
- Yoshihiko NAKANISHI
- Naokuni Sakiyama
- Hiroki Nishikawa (ORCID: https://orcid.org/0009-0009-0488-3297)
- Azusa Hara (ORCID: https://orcid.org/0000-0001-6958-7864)
- Kazuki Kakimoto (ORCID: https://orcid.org/0000-0003-0564-2793)
- Shoko Arimitsu
- Keijiro Numa (ORCID: https://orcid.org/0009-0003-6081-5287)
- Shirô Nakamura (ORCID: https://orcid.org/0000-0003-4435-1294)
- Noboru Mizuta
- Ryoji Koshiba (ORCID: https://orcid.org/0009-0003-6607-0589)
- Kei Nakazawa (ORCID: https://orcid.org/0000-0002-0086-0671)
- Yuki Hirata (ORCID: https://orcid.org/0000-0002-3686-4690)
- Hiroaki Ito (ORCID: https://orcid.org/0000-0001-8503-141X)
- Ken Kawakami
- Takako Miyazaki (ORCID: https://orcid.org/0000-0003-3255-4932)
- Naohiko Kinoshita (ORCID: https://orcid.org/0000-0002-8074-2834)
- Mitsuyuki Murano
- Takuya Inoue (ORCID: https://orcid.org/0000-0002-9771-141X)
Institutions
- Inoue Hospital (JP)
- Teine Keijinkai Hospital (JP)
- Takatsuki General Hospital (JP)
- Municipal Hirakata City Hospital (JP)
- Osaka University of Pharmaceutical Sciences (JP)
Publication Details
- Journal
- Intestinal Research
- Published
- 2025-08-12
- DOI
- https://doi.org/10.5217/ir.2025.00066
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82